Information  X 
Enter a valid email address

Futura Medical PLC (FUM)

  Print      Mail a friend       Annual reports

Wednesday 13 June, 2018

Futura Medical PLC

Result of AGM

RNS Number : 3363R
Futura Medical PLC
13 June 2018

For immediate release

13 June 2018






Futura Medical plc

("Futura" or the "Company")


Result of AGM



Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, confirms that all resolutions were duly passed at its Annual General Meeting held today.




For any further information please contact:



Futura Medical plc


James Barder, Chief Executive


Tel: +44 (0)1483 685 670

mail to: [email protected]




N+1 Singer (Nominated Adviser and Broker)


Aubrey Powell / Liz Yong


Tel:+44 (0) 20 7496 3000




For media enquiries please contact:





Mark Court / Sophie Wills / Tilly Abraham

Tel: +44 (0)20 7466 5000



Notes to Editors


Futura Medical plc


Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.


Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t